Study Evaluating the Performance and Safety in the Medium and Long Term of Global D ZygoFixU System

Global D

Status

Enrolling

Conditions

Dental Implants

Treatments

Other: Dental implant surgery with ZygoFixU implants

Study type

Interventional

Funder types

Industry

Identifiers

NCT06960460

2302-G-ZYGO-C

Details and patient eligibility

About

Global D has developed an zygomatic implant prosthetic system (ZygoFixU range): zygomatic implants, prosthetic parts and associated instruments. These devices have a design similar to other zygomatic implants on the market and are therefore not innovative. These non-CE marked devices are assessed during investigation 2302-G-ZYGO-C for their performance and for their short- and medium-term safety. These implants will be placed using specific instruments, by oral or cranio-maxillofacial surgeons with significant experience in the placement of zygomatic implants and trained in clinical research.

Full description

Study design: Interventional pivotal study involving humans, prospective with continuous series, multicentre, European, open-label, non-comparative.

Clinical investigation classification: class 2 clinical investigation according to ANSM in France, aiming at establishing the conformity of a class IIb, non CE-marked medical device. Clinical investigation to demonstrate device compliance, in accordance with Article 62.1 of the MDR.

Investigators: Patient recruitment and follow-up will be carried out by dental surgeons or oral surgeons/stomatologists in France and Italy. 11 sites will participate in the CI in 2 countries (Italy and France).

Objective: To assess the performance of the ZygoFixU implant-prosthetic system by measuring the survival rate at 1 year postoperatively.

Population: Adult male or female patients, whose growth and development of the maxillary bone is complete, partially or completely edentulous with advanced atrophy of the maxillary bone (grades IV, V and VI according to the Cawood and Howell classification if used).

Enrollment

99 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Adult male or female patient,
Patient whose growth and development of the maxillary bone is complete according to the investigator's judgement,
Partially or completely edentulous patient,
Patient with advanced maxillary atrophy (grades IV, V and VI according to the Cawood and Howell classification if used),
Patient requiring implant treatment with Global D zygomatic implants (placement of two or four implants),
Patient with acceptable oral opening (>3 cm measured anteriorly),
Patient able to read, understand and answer the quality-of-life questionnaire of the investigation and able to give consent,
Patient agreeing to comply with the protocol design and to send his/her follow-up data, even in the event of a move,
Patient having signed the consent form,
In France, patient affiliated to a social security scheme.

Exclusion criteria

Patient's state of health at enrolment:
- General contraindications to implant surgery
- Patient with zygomatic bone disease
- Patient with untreated periodontal disease
- Patient with acute or chronic infection in the implant placement area, or systemic infection, including acute or chronic maxillary sinusitis
- Patient with acute or chronic inflammation in the implant placement area, or systemic inflammation,
- Patient with uncontrolled diabetes (unstable blood glucose)
- Patient with immunodeficiencies or using immunosuppressants
- Patient who received radiation of more than +70 Gy to the head and neck region
- Patient using intravenous aminobisphosphonates within 5 years prior to surgery
Patient who are smokers (>10 cigarettes/day) or with alcohol or drug addiction
Person placed under legal protection (this includes guardianship, curatorship and legal protection).
Pregnant or breastfeeding women